OneMain Holdings, Inc.

Fundamentals6.1
Price Action6.7
News Sentiment6.0
AI Rating
6.0

Key Drivers

  • Strong margins
  • Heavy leverage
  • Solid cash flow

AI
AI Summary

6.0

OMF looks less like a simple high-yield lender and more like a cash-generating but credit-sensitive business: the dividend is currently covered by strong free cash flow, yet upside is now capped by rising provisions, high leverage, and reliance on steady ABS/funding markets, so investors should treat it as an execution-and-credit-cycle trade rather than a pure income play.

CashFlow
CreditRisk
Leverage‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

6.1

Key Financial Insights:

  • Strong margins
  • Heavy leverage
  • Solid cash flow

OMF combines strong profitability and free cash flow with an attractive dividend yield and moderate valuation, but high leverage and a stretched payout ratio create meaningful solvency risk.

CashFlow
Leverage

Price Behavior

6.7
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Uptrend intact
  • Resistance test
  • Support holding

OMF has risen about 11% over the last month in a clear higher-high/higher-low uptrend, but it now looks short-term extended as it tests resistance near $65.70-$66.00.

bullish
cautious
Support Level: $64.00, then $63.10
Resistance Level: $65.70-$66.00

Fast recent run-up has left the stock somewhat extended, increasing short-term profit-taking risk

Sentiment & News

6.0

Key News Insights:

  • Earnings in line
  • Credit trends improving
  • ABS funding boost

OneMain's Q2 results met expectations with stable receivables growth, improving delinquencies, and a $1.05 dividend, while recent ABS issuance and a larger Fifth Third stake support funding and sentiment despite higher credit costs.

Earnings

Mixed-to-positive impact, as steady earnings and capital returns are supportive, but rising credit costs still limit upside